← Open Payments lookup

KEVIN WALDO: Open Payments

NPI 1356018543 · WARSAW, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,159 in 59 payments from 15 companies in 2025. Trend: 2023 $1,964 · 2024 $2,300 · 2025 $1,159

Food & beverage: $1,159
CompanyPaymentsAmount
ABBVIE INC.29$482
Janssen Biotech, Inc.8$231
Takeda Pharmaceuticals U.S.A., Inc.4$82
QOL Medical, LLC4$70
GENZYME CORPORATION2$50
Madrigal Pharmaceuticals2$49
VIVUS LLC2$33
Regeneron Healthcare Solutions, Inc.1$30
Azurity Pharmaceuticals, Inc.1$23
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$19

Products named: TREMFYA, RINVOQ, CREON, DUPIXENT, Sucraid, EOHILIA, LINZESS, REZDIFFRA.

Industry payments across IN — which companies pay providers there.